Pharmacom Biovet Inc
OTC:PHMB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pharmacom Biovet Inc
EPS (Diluted)
Pharmacom Biovet Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pharmacom Biovet Inc
OTC:PHMB
|
EPS (Diluted)
$0
|
CAGR 3-Years
81%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Universal Health Services Inc
NYSE:UHS
|
EPS (Diluted)
$23
|
CAGR 3-Years
36%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
|
Encompass Health Corp
NYSE:EHC
|
EPS (Diluted)
$5
|
CAGR 3-Years
27%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
EPS (Diluted)
$15
|
CAGR 3-Years
61%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
EPS (Diluted)
$28
|
CAGR 3-Years
14%
|
CAGR 5-Years
21%
|
CAGR 10-Years
19%
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
EPS (Diluted)
$5
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
|
Pharmacom Biovet Inc
Glance View
PharmaCom BioVet, Inc. engages in the provision of locating, identifying, and introducing cancer compounds and treatment procedures into the veterinary market. The company is headquartered in Raleigh, North Carolina and currently employs 2 full-time employees. The company went IPO on 2001-06-06. The firm is introducing canine bone marrow transplantation. ABV Gold Inc. was a gold and precious metals mining company founded as an exploration company to locate, explore and mine deposits. The firm holds claims in three different properties: The Toiyabe Uranium, the Parin Mining, and the Dun Glen properties.
See Also
What is Pharmacom Biovet Inc's EPS (Diluted)?
EPS (Diluted)
-0.7
USD
Based on the financial report for Sep 30, 2004, Pharmacom Biovet Inc's EPS (Diluted) amounts to -0.7 USD.
What is Pharmacom Biovet Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
81%
Over the last year, the EPS (Diluted) growth was -17%. The average annual EPS (Diluted) growth rates for Pharmacom Biovet Inc have been 81% over the past three years .
